Authors:
Amann, K
Koch, A
Hofstetter, J
Gross, ML
Haas, C
Orth, SR
Ehmke, H
Rump, LC
Ritz, E
Citation: K. Amann et al., Glomerulosclerosis and progression: Effect of subantihypertensive doses ofalpha and beta blockers, KIDNEY INT, 60(4), 2001, pp. 1309-1323
Authors:
Amann, K
Rump, LC
Simonaviciene, A
Oberhauser, V
Wessels, S
Orth, SR
Gross, ML
Koch, A
Bielenberg, GW
Van Kats, JP
Ehmke, H
Mall, G
Ritz, E
Citation: K. Amann et al., Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats, J AM S NEPH, 11(8), 2000, pp. 1469-1478
Citation: Sr. Orth et al., Glial cell line-derived neurotrophic factor (GDNF) is expressed in the human kidney and is a growth factor for human mesangial cells, NEPH DIAL T, 15(5), 2000, pp. 589-595
Citation: Sr. Orth et al., Smoking as a risk factor for end-stage renal failure in patients with primary renal disease, CONTR NEPHR, 130, 2000, pp. 109-123
Citation: E. Ritz et Sr. Orth, Adverse effect of smoking on the renal outcome of patients with primary hypertension, AM J KIDNEY, 35(4), 2000, pp. 767-769
Authors:
Amann, K
Gassmann, P
Buzello, M
Orth, SR
Tornig, J
Gross, ML
Magener, A
Mall, G
Ritz, E
Citation: K. Amann et al., Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats, KIDNEY INT, 58(1), 2000, pp. 153-161
Authors:
Orth, SR
Odoni, G
Amann, K
Strzelczyk, P
Raschack, M
Ritz, E
Citation: Sr. Orth et al., The ETA receptor blocker LU 135252 prevents chronic transplant nephropathyin the "Fisher to Lewis" model, J AM S NEPH, 10(2), 1999, pp. 387-391